Skip to main content
Lyrea avatar

Not yet reviewed — this article is pending editorial review by Lyrea.

Citation noticeOur citation system is being overhauled

References and citation markers may currently be incomplete, mismatched, or incorrect. This system is being rebuilt and reviewed before the full site launch.

Sulbutiamine

This article is a stubmissing:
Interactions
Tolerance
Harm Potential
Legality
Sulbutiamine molecule structureSulbutiamine molecule structure

Sulbutiamine is a synthetic derivative of thiamine (vitamin B1) used as a nootropic and stimulant. It emerged from 1950s Japanese efforts to develop thiamine derivatives with better bioavailability than thiamine itself, alongside compounds such as fursultiamine and benfotiamine. It is prescribed for asthenia and thiamine deficiency, and is also sold as a dietary supplement. Consistent use may reduce dopamine output over time.

Dosage & Duration

Dosage

Doses are population estimates that vary widely between individuals.

Moderate200-400 mg

While daily use can result in tolerance and paradoxical drowsiness, increasing the dose is strongly discouraged and side effects can include diarrhea, bladder infections, bronchitis, back pain, abdominal pain, insomnia, constipation, gastroenteritis, headache, vertigo, and sore throat.

Duration

Onset20-40 minutes
Total6-10 hours

Subjective Effects

Legacy content. A statistically backed ontology from Mindstate Design Labs is coming soon.

Sulbutiamine is used as a nootropic and mild stimulant, with users reporting improved mood, motivation, and mental performance. Effects are subtle rather than perceptual, and daily use can lead to tolerance and a paradoxical drowsiness rather than continued stimulation.

Physical

The physical profile is stimulant-like and oriented toward reducing weakness and fatigue. Adverse physical effects reported in clinical use include headache, gastrointestinal discomfort, insomnia, and vertigo.

Uncomfortable

Cognitive

Reported cognitive effects centre on enhanced memory and focus, alongside an improved mood and increased motivation. Poor concentration and fatigue-related mental sluggishness are the states it is most often taken to address.

Enhancements

Motivation enhancement

Pharmacology

Pharmacodynamics

Sulbutiamine is a thiamine derivative described as a potent cholinergic. Its pharmacology has been examined in mice and rats, where it may raise thiamine phosphate levels in the brain more effectively than benfotiamine and fursultiamine, although this has not been fully verified. It has also been reported to reduce dopamine output over time with consistent use, and studies in retinal ganglion cells indicate it helps prevent apoptotic cell death caused by trophic factor deprivation.

Pharmacokinetics

Sulbutiamine belongs to a group of thiamine disulfides developed to improve on the bioavailability of thiamine itself. These compounds are hydrophobic, allowing them to pass readily from the intestines into the bloodstream, where they are reduced to thiamine by cysteine or glutathione.

Interactions

Interactions not written up yet

An unlisted combination is an unknown one, not a safe one. Check a dedicated combination chart before mixing.

Check TripSit

Tolerance

Tolerance not written up yet

Harm Potential

Harm Potential not written up yet

History & Culture

Sulbutiamine emerged from research in the 1950s, conducted mainly in Japan, aimed at developing thiamine derivatives with better bioavailability than thiamine itself. That work led to the identification of allicin (diallyl thiosulfinate) in garlic, which served as a model for medicinal chemistry

Legality

Legality not written up yet

Article Status

  • Josie Kins avatar
    Step 1 · Automated synthesis

    An autonomous workflow built by Josie Kins compiled this article's foundation from information published across the web.

  • Step 2 · First-pass reviewPending

    Not yet reviewed — this article is pending editorial review by Lyrea.

  • Step 3 · Citation reviewPending

    No one has reviewed this article's citations yet. That second pass checks each claim against the source it cites.

Recent changes7 human edits · latest

Times are UTCNewest first

24 January 2026

  1. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  2. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  3. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  4. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  5. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  6. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  7. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

All changes to this article · Site-wide recent changes

Suggest an edit

Spotted a mistake, an outdated claim, or something missing from the Sulbutiamine article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.

Wish to give generalised feedback? You can do so here.